Pierre Jullian
Director of Finance/CFO at Debiopharm International SA
Network origin in Pierre Jullian first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Debiopharm International SA
 Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland.
16
| Subsidiary | Pharmaceuticals: Major | 16 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Pierre Jullian via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BTG | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Kiel | College/University | Doctorate Degree | |
| University of Strathclyde | College/University | Undergraduate Degree | |
| University of Warwick | College/University | Doctorate Degree | |
| University of Fribourg | College/University | Doctorate Degree | |
| University of Geneva | College/University | Undergraduate Degree | |
| Swiss Federal Institute of Technology | College/University | Masters Business Admin | |
| University of Lausanne | College/University | Graduate Degree Masters Business Admin | |
| University of Bern | College/University | Corporate Officer/Principal | |
| Haute école spécialisée de Suisse occidentale University | College/University | Undergraduate Degree | |
| École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin | |
| Institut d’Administration des Entreprises | College/University | Masters Business Admin | |
| King's College London | College/University | Graduate Degree | |
| University of Lyon | College/University | Undergraduate Degree | |
SOCAR Research SA
 SOCAR Research SA BiotechnologyHealth Technology SOCAR Research SA provides clinical research services. It provides services in the areas which include cardiovascular and related, cachexia, hematology, hypertension, metabolic, nephrology, nutraceuticals and oncology telemedicine. The firm's technology include e-SOCDAT is an e-clinical solution which provides e-design, e-data and e-data services. It serves the biotechnology, consumer healthcare, medical device, pharmaceutical, contract research organization and academic institutions. The company was founded in 1986 and is headquartered in Nyon, Switzerland. | Biotechnology | Corporate Officer/Principal | |
Anteis SA
 Anteis SA Medical/Nursing ServicesHealth Services Anteis SA modifies and functionalizes injectable hyaluronic acid for medical applications. The firm serves in Asthetic dermatology. The company was founded by Gilles Bos Gilles in March 2003 and is headquartered in Plan-les-Ouates, Switzerland. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
Biocartis SA
 Biocartis SA Medical SpecialtiesHealth Technology Biocartis SA develops molecular diagnostic solutions. It focuses on Oncology. The firm’s products include Idylla and Oncology assays and mutation tests. It also provides instant access to personalized medicine for patients. The company was founded by Rudi Pauwels in 2007 and is headquartered in Lausanne, Switzerland. | Medical Specialties | Director/Board Member | |
| Debio Recherche Pharmaceutique SA | President | ||
| BERGENBIO ASA | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| NUCANA PLC | Biotechnology | Chief Operating Officer | |
Med Discovery SA
 Med Discovery SA BiotechnologyHealth Technology Med Discovery SA is a Swiss biopharmaceutical company that develops treatments for cancers. The private company was founded by David Luc Deperthes. | Biotechnology | Founder | |
Centre Hospitalier Universitaire Vaudois
 Centre Hospitalier Universitaire Vaudois Hospital/Nursing ManagementHealth Services Centre Hospitalier Universitaire Vaudois is a university hospital located in Lausanne, CH. The SwitzerlandUV is also a renowned center of medical education and research, collaborating with the Faculty of Biology and Medicine of the University of Lausanne and the Swiss Federal Institute of Technology in Lausanne (EPFL). It has 16 clinical and medico-technical departments and is known for its academic achievements in healthcare, research, and teaching. The vast campus in the lake region is home to these institutions. The CEO of the Swiss company is Nicolas Demartines. | Hospital/Nursing Management | Corporate Officer/Principal | |
Debiopharm Innovation Fund /Management/
 Debiopharm Innovation Fund /Management/ Investment ManagersFinance Debiopharm Innovation Fund SA develops, manufactures, and markets diagnostic systems. It seeks to invest in the biotechnology, diagnostics, and pharmaceutical industries with a focus on biomarker development, and large molecule capabilities. The firm mission is to invest in innovative diagnostic companies developing platforms and content to complement in-house diagnostic activities, give insight into cutting-edge diagnostics and facilitate access to new technologies. The company was founded in 1979 and is headquartered in Fribourg, Switzerland. | Investment Managers | Director/Board Member Chief Executive Officer | |
| BIOCARTIS GROUP NV | Medical Specialties | Director/Board Member Director/Board Member | |
Dynacure SA
 Dynacure SA Medical/Nursing ServicesHealth Services Dynacure SA is a clinical-stage company, which engages in developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Its product includes, DYN101, an antisense oligonucleotide, or ASO, designed to be a disease-modifying medicine for treatment of the majority of ntronuclear myopathies patients with multiple mutations in adult and pediatric populations. The company was founded by Belinda Cowling in 2016 and is headquartered in Illikirch-Graffenstaden, France. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
| VIRAX BIOLABS GROUP LIMITED | Financial Conglomerates | Chief Operating Officer |
Statistics
International
| Switzerland | 16 |
| United Kingdom | 7 |
| France | 5 |
| Ireland | 2 |
| Germany | 2 |
Sectoral
| Consumer Services | 14 |
| Health Technology | 10 |
| Health Services | 4 |
| Finance | 3 |
| Commercial Services | 2 |
Operational
| Corporate Officer/Principal | 19 |
| Director/Board Member | 12 |
| Undergraduate Degree | 5 |
| Masters Business Admin | 4 |
| Doctorate Degree | 4 |
Most connected contacts
- Stock Market
- Insiders
- Pierre Jullian
- Company connections
